Medworth Acquisition Corp (MWRX) 8.16 $MWRX
MedWorth Acquisition Corp. Completes Sale of Additional Common Shares
GlobeNewswire - Mon Jul 08, 11:00AM CDT
MedWorth Acquisition Corp. (Nasdaq:MWRX), a newly-formed blank check company focused on the U.S. specialty pharmacy, infusion pharmacy and drug distribution sectors (the "Company"
, announced today that it has completed the sale of an additional 990,000 shares of common stock (the "Additional Shares" pursuant to the July 3, 2013 exercise in full of the over-allotment option granted to EarlyBirdCapital, Inc. ("EBC" , the lead underwriter of the Company's initial public offering ("IPO" of 6,600,000 shares of common stock, which closed on July 2, 2013. The Additional Shares were sold at the offering price of $8.00 per share, generating gross proceeds to the Company of $7,920,000, and proceeds net of the underwriters' discount of $7,642,800. Simultaneously with the closing of the sale of the Additional Shares, the Company raised, via private placement, an additional $633,600 through the sale of an additional 79,200 shares (at $8.00 per share) to Anthony Minnuto, the Company's Chairman.
MedWorth Acquisition Corp. Completes Initial Public Offering
GlobeNewswire - Tue Jul 02, 12:31PM CDT
MedWorth Acquisition Corp. (Nasdaq:MWRX), a newly-formed blank check company focused on the U.S. specialty pharmacy, infusion pharmacy and drug distribution sectors (the "Company" , announced today that it has completed its initial public offering of 6,600,000 shares of Common Stock (the "Public Shares" . The shares were sold at an offering price of $8.00 per share, generating gross proceeds of $52,800,000 to the Company. In addition, the Company has granted the underwriters a 45-day over-allotment option to purchase up to an additional 990,000 shares. EarlyBirdCapital, Inc. acted as the representative of the underwriters of the initial public offering. Copies of the final prospectus relating to the offering may be obtained for free by visiting the U.S. Securities and Exchange Commission's website at http://www.sec.gov. Alternatively, a copy of the prospectus relating to the offering may be obtained from EarlyBirdCapital, Inc., 275 Madison Avenue, 27th Floor, New York, New York 10016.
MedWorth Acquisition Corp. Completes Sale of Additional Common Shares
GlobeNewswire - Mon Jul 08, 11:00AM CDT
MedWorth Acquisition Corp. (Nasdaq:MWRX), a newly-formed blank check company focused on the U.S. specialty pharmacy, infusion pharmacy and drug distribution sectors (the "Company"
, announced today that it has completed the sale of an additional 990,000 shares of common stock (the "Additional Shares" pursuant to the July 3, 2013 exercise in full of the over-allotment option granted to EarlyBirdCapital, Inc. ("EBC" , the lead underwriter of the Company's initial public offering ("IPO" of 6,600,000 shares of common stock, which closed on July 2, 2013. The Additional Shares were sold at the offering price of $8.00 per share, generating gross proceeds to the Company of $7,920,000, and proceeds net of the underwriters' discount of $7,642,800. Simultaneously with the closing of the sale of the Additional Shares, the Company raised, via private placement, an additional $633,600 through the sale of an additional 79,200 shares (at $8.00 per share) to Anthony Minnuto, the Company's Chairman. MedWorth Acquisition Corp. Completes Initial Public Offering
GlobeNewswire - Tue Jul 02, 12:31PM CDT
MedWorth Acquisition Corp. (Nasdaq:MWRX), a newly-formed blank check company focused on the U.S. specialty pharmacy, infusion pharmacy and drug distribution sectors (the "Company"
, announced today that it has completed its initial public offering of 6,600,000 shares of Common Stock (the "Public Shares" . The shares were sold at an offering price of $8.00 per share, generating gross proceeds of $52,800,000 to the Company. In addition, the Company has granted the underwriters a 45-day over-allotment option to purchase up to an additional 990,000 shares. EarlyBirdCapital, Inc. acted as the representative of the underwriters of the initial public offering. Copies of the final prospectus relating to the offering may be obtained for free by visiting the U.S. Securities and Exchange Commission's website at http://www.sec.gov. Alternatively, a copy of the prospectus relating to the offering may be obtained from EarlyBirdCapital, Inc., 275 Madison Avenue, 27th Floor, New York, New York 10016. 
